Literature DB >> 11067805

Association of serum bilirubin concentration with risk of coronary artery disease.

M Mayer1.   

Abstract

BACKGROUND: Lipid oxidation and formation of oxygen radicals are important elements of arterial plaque formation and atherosclerosis, and are involved in the pathophysiology of coronary artery disease (CAD). Because bilirubin has antioxidant properties, it has been suggested that it may have a protective role in the atherosclerotic process. APPROACH: This review examines in vitro and in vivo studies indicating that bilirubin inhibits lipid oxidation and oxygen radical formation. Experimental and epidemiological evidence is presented that suggests that bilirubin may serve as a physiological antioxidant providing protection against atherosclerosis and CAD. Special attention is focused on studies that noted an inverse relationship between plasma bilirubin concentration and cardiovascular morbidity. CONTENT: Serum bilirubin concentrations in the upper portion of the reference interval reportedly reduce atherogenic risk and provide protection against CAD. In contrast, serum bilirubin concentrations in the lower portion of the reference interval may be associated with increased risk of ischemic heart disease.
SUMMARY: Taken together, the evidence presented in this review supports the concept that bilirubin, via its antioxidant potential, has antiatherogenic properties and that an inverse relationship exists between circulating bilirubin concentrations and risk of CAD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067805

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  57 in total

1.  Alterations in aortic antioxidant components in an experimental model of atherosclerosis: a time-course study.

Authors:  David V Godin; Cathleen R Nichols; Kenneth A Hoekstra; Maureen E Garnett; Kimberly M Cheng
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  Functional polyethersulfone particles for the removal of bilirubin.

Authors:  Xin Jiang; Tao Xiang; Yi Xie; Rui Wang; Weifeng Zhao; Shudong Sun; Chang-Sheng Zhao
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

3.  In vitro analysis of the effect of hyperbilirubinemia on rabbit ureter and bladder.

Authors:  Nergis Murat; Belde Kasap; Salih Kavukcu; Alper Soylu; Mehmet Türkmen; Sedef Gidener
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

Review 4.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

Review 5.  Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis.

Authors:  Jun Wei Lim; John Dillon; Michael Miller
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.

Authors:  Vijith Vijayan; Sebastian Mueller; Eveline Baumgart-Vogt; Stephan Immenschuh
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

7.  Dubin-Johnson syndrome coinciding with colon cancer and atherosclerosis.

Authors:  Eva Sticova; Milan Elleder; Helena Hulkova; Ondrej Luksan; Martin Sauer; Irena Wunschova-Moudra; Jan Novotny; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

8.  Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C.

Authors:  Danielle Venturini; Andréa Name Colado Simão; Décio Sabbatini Barbosa; Edson Lopes Lavado; Victor Emanuel Soares Narciso; Isaias Dichi; Jane Bandeira Dichi
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

9.  Relationship between serum bilirubin concentration and nondipper hypertension.

Authors:  Mehmet Demir; Canan Demir; Serdar Keçeoğlu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

10.  Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).

Authors:  Elaine N Videan; Christopher B Heward; Kajal Chowdhury; John Plummer; Yali Su; Richard G Cutler
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.